IL17RC
Basic information
Region (hg38): 3:9917074-9933630
Links
Phenotypes
GenCC
Source:
- chronic mucocutaneous candidiasis (Supportive), mode of inheritance: AD
- candidiasis, familial, 9 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Candiasis, familial, 9 | AR | Allergy/Immunology/Infectious | Individuals have been described as susceptible to Candida albicansinfections, and awareness may allow early detection and early treatment of infections | Allergy/Immunology/Infectious | 25918342 |
ClinVar
This is a list of variants' phenotypes submitted to
- Candidiasis,_familial,_9 (738 variants)
- not_specified (108 variants)
- not_provided (42 variants)
- IL17RC-related_disorder (13 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL17RC gene is commonly pathogenic or not. These statistics are base on transcript: NM_000153460.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 177 | 12 | 198 | |||
| missense | 335 | 20 | 361 | |||
| nonsense | 12 | 15 | ||||
| start loss | 0 | |||||
| frameshift | 10 | 13 | ||||
| splice donor/acceptor (+/-2bp) | 12 | |||||
| Total | 1 | 7 | 375 | 198 | 18 |
Highest pathogenic variant AF is 0.0003079194
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| IL17RC | protein_coding | protein_coding | ENST00000295981 | 19 | 16557 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.30e-14 | 0.951 | 124302 | 10 | 1436 | 125748 | 0.00577 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.0924 | 441 | 447 | 0.988 | 0.0000237 | 4973 |
| Missense in Polyphen | 81 | 91.844 | 0.88193 | 1166 | ||
| Synonymous | -1.26 | 224 | 201 | 1.11 | 0.0000117 | 1679 |
| Loss of Function | 2.28 | 29 | 45.6 | 0.636 | 0.00000241 | 447 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00756 | 0.00727 |
| Ashkenazi Jewish | 0.00159 | 0.000993 |
| East Asian | 0.000437 | 0.000435 |
| Finnish | 0.00565 | 0.00505 |
| European (Non-Finnish) | 0.0111 | 0.00926 |
| Middle Eastern | 0.000437 | 0.000435 |
| South Asian | 0.00196 | 0.00147 |
| Other | 0.0109 | 0.00834 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the heterodimer formed by IL17A and IL17B as part of a heterodimeric complex with IL17RA (PubMed:18684971). Has also been shown to be the cognate receptor for IL17F and to bind IL17A with high affinity without the need for IL17RA (PubMed:17911633). Activation of IL17RC leads to induction of expression of inflammatory chemokines and cytokines such as CXCL1 (PubMed:16785495). {ECO:0000269|PubMed:16785495, ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971}.; FUNCTION: Isoform 6: Does not bind IL17A or IL17F. {ECO:0000269|PubMed:16785495}.; FUNCTION: Isoform 8: Receptor for both IL17A and IL17F. {ECO:0000269|PubMed:16785495}.;
- Disease
- DISEASE: Candidiasis, familial, 9 (CANDF9) [MIM:616445]: A disorder characterized by altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans. {ECO:0000269|PubMed:25918342}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- IL-17 signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);IL17 signaling pathway
(Consensus)
Intolerance Scores
- loftool
- 0.931
- rvis_EVS
- 2.09
- rvis_percentile_EVS
- 97.87
Haploinsufficiency Scores
- pHI
- 0.203
- hipred
- N
- hipred_score
- 0.172
- ghis
- 0.407
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.252
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il17rc
- Phenotype
- immune system phenotype; normal phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- defense response to fungus;granulocyte chemotaxis;interleukin-17-mediated signaling pathway;positive regulation of cytokine production involved in inflammatory response;positive regulation of interleukin-6 secretion
- Cellular component
- plasma membrane;cell surface;integral component of membrane
- Molecular function
- signaling receptor binding;interleukin-17 receptor activity